A carregar...

Sitagliptin (MK0431) Inhibition of Dipeptidyl Peptidase IV Decreases Nonobese Diabetic Mouse CD4(+) T-Cell Migration Through Incretin-Dependent and -Independent Pathways

OBJECTIVE: Treatment of NOD mice with the dipeptidyl peptidase-IV (DPP-IV) inhibitor sitagliptin preserved islet transplants through a pathway involving modulation of splenic CD4(+) T-cell migration. In the current study, effects of sitagliptin on migration of additional subsets of CD4(+) T-cells we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Su-Jin, Nian, Cuilan, McIntosh, Christopher H.S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889774/
https://ncbi.nlm.nih.gov/pubmed/20368408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1618
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!